 Maria Caino
Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria | 17 | 2023 | 751 | 3.020 |
Why?
| | Neoplasm Metastasis | 6 | 2022 | 530 | 1.440 |
Why?
| | Mitochondrial Dynamics | 6 | 2022 | 23 | 1.360 |
Why?
| | Neoplasms | 12 | 2022 | 2106 | 1.330 |
Why?
| | Vesicular Transport Proteins | 3 | 2018 | 83 | 1.220 |
Why?
| | Nerve Tissue Proteins | 4 | 2019 | 529 | 1.120 |
Why?
| | Protein Kinase C-epsilon | 5 | 2012 | 27 | 0.990 |
Why?
| | Mitochondrial Proteins | 4 | 2022 | 219 | 0.800 |
Why?
| | Neoplasm Proteins | 4 | 2020 | 385 | 0.790 |
Why?
| | Neoplasm Invasiveness | 5 | 2022 | 445 | 0.780 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 4 | 2013 | 975 | 0.730 |
Why?
| | Microtubule-Associated Proteins | 2 | 2021 | 174 | 0.710 |
Why?
| | Cell Movement | 9 | 2023 | 867 | 0.670 |
Why?
| | Cytoskeleton | 4 | 2018 | 177 | 0.660 |
Why?
| | Signal Transduction | 12 | 2022 | 4525 | 0.660 |
Why?
| | Lung Neoplasms | 5 | 2013 | 2223 | 0.630 |
Why?
| | Prostatic Neoplasms | 4 | 2022 | 925 | 0.620 |
Why?
| | Membrane Proteins | 6 | 2023 | 1022 | 0.580 |
Why?
| | Cell Line, Tumor | 17 | 2022 | 2725 | 0.570 |
Why?
| | Cell Proliferation | 8 | 2022 | 2199 | 0.570 |
Why?
| | rho GTP-Binding Proteins | 1 | 2016 | 61 | 0.540 |
Why?
| | Enzyme Inhibitors | 3 | 2015 | 752 | 0.510 |
Why?
| | rac GTP-Binding Proteins | 2 | 2012 | 34 | 0.490 |
Why?
| | Antineoplastic Agents | 5 | 2015 | 1897 | 0.470 |
Why?
| | Protein Kinase C | 3 | 2013 | 275 | 0.440 |
Why?
| | Liver Neoplasms, Experimental | 1 | 2013 | 26 | 0.440 |
Why?
| | Protein Kinase C-delta | 4 | 2023 | 70 | 0.430 |
Why?
| | Cellular Senescence | 4 | 2020 | 153 | 0.420 |
Why?
| | Proto-Oncogene Proteins c-akt | 5 | 2022 | 400 | 0.400 |
Why?
| | Bone Neoplasms | 1 | 2013 | 194 | 0.370 |
Why?
| | Carcinoma | 1 | 2012 | 199 | 0.350 |
Why?
| | Stress, Physiological | 1 | 2013 | 378 | 0.350 |
Why?
| | NIH 3T3 Cells | 4 | 2020 | 137 | 0.330 |
Why?
| | Animals | 18 | 2023 | 31839 | 0.320 |
Why?
| | Mice | 12 | 2022 | 14936 | 0.290 |
Why?
| | Focal Adhesions | 2 | 2019 | 42 | 0.280 |
Why?
| | Dihydroxydihydrobenzopyrenes | 1 | 2006 | 1 | 0.280 |
Why?
| | Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2006 | 20 | 0.280 |
Why?
| | G2 Phase | 1 | 2006 | 31 | 0.280 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2009 | 312 | 0.280 |
Why?
| | Energy Metabolism | 4 | 2016 | 724 | 0.280 |
Why?
| | RNA Interference | 6 | 2016 | 437 | 0.260 |
Why?
| | Guanidines | 3 | 2015 | 33 | 0.260 |
Why?
| | Humans | 33 | 2023 | 114937 | 0.260 |
Why?
| | Gene Expression Regulation, Neoplastic | 4 | 2016 | 1148 | 0.250 |
Why?
| | A549 Cells | 3 | 2023 | 51 | 0.250 |
Why?
| | Cellular Reprogramming | 2 | 2016 | 84 | 0.240 |
Why?
| | Transcription, Genetic | 1 | 2011 | 1317 | 0.240 |
Why?
| | Cell Division | 1 | 2006 | 759 | 0.240 |
Why?
| | Protein Kinases | 1 | 2006 | 307 | 0.240 |
Why?
| | Genome-Wide Association Study | 1 | 2011 | 1197 | 0.240 |
Why?
| | Ubiquitin-Protein Ligases | 2 | 2023 | 139 | 0.230 |
Why?
| | MCF-7 Cells | 3 | 2020 | 105 | 0.220 |
Why?
| | Phosphatidylinositol 3-Kinases | 2 | 2015 | 330 | 0.220 |
Why?
| | Dynamins | 2 | 2019 | 29 | 0.210 |
Why?
| | Enzyme Activation | 4 | 2023 | 790 | 0.210 |
Why?
| | Radiation Tolerance | 1 | 2023 | 92 | 0.210 |
Why?
| | HSP90 Heat-Shock Proteins | 2 | 2013 | 43 | 0.210 |
Why?
| | Ubiquitination | 2 | 2023 | 86 | 0.200 |
Why?
| | Mice, Nude | 3 | 2016 | 635 | 0.200 |
Why?
| | Melanoma | 2 | 2020 | 631 | 0.200 |
Why?
| | Peptide Elongation Factors | 1 | 2022 | 13 | 0.200 |
Why?
| | Neoplasm Transplantation | 2 | 2013 | 232 | 0.200 |
Why?
| | RNA, Small Interfering | 3 | 2013 | 543 | 0.200 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 2324 | 0.190 |
Why?
| | Sorting Nexins | 1 | 2021 | 10 | 0.190 |
Why?
| | Transport Vesicles | 1 | 2021 | 18 | 0.190 |
Why?
| | Autophagy | 2 | 2021 | 234 | 0.180 |
Why?
| | Coenzyme A Ligases | 1 | 2020 | 11 | 0.180 |
Why?
| | Apoptosis | 6 | 2015 | 2371 | 0.180 |
Why?
| | Trans-Activators | 1 | 2022 | 368 | 0.170 |
Why?
| | Prostatic Neoplasms, Castration-Resistant | 1 | 2019 | 41 | 0.170 |
Why?
| | Myosin Type V | 1 | 2019 | 9 | 0.160 |
Why?
| | Aging | 1 | 2009 | 1621 | 0.160 |
Why?
| | RNA-Binding Proteins | 1 | 2022 | 344 | 0.160 |
Why?
| | Inhibitor of Apoptosis Proteins | 2 | 2016 | 42 | 0.160 |
Why?
| | Oxidative Phosphorylation | 2 | 2019 | 156 | 0.160 |
Why?
| | Myosins | 1 | 2019 | 128 | 0.160 |
Why?
| | Phosphorylation | 5 | 2015 | 1572 | 0.150 |
Why?
| | Androgens | 1 | 2019 | 167 | 0.150 |
Why?
| | Drug Resistance, Neoplasm | 3 | 2020 | 642 | 0.150 |
Why?
| | Myosin Heavy Chains | 1 | 2019 | 177 | 0.150 |
Why?
| | Drug Evaluation, Preclinical | 2 | 2015 | 165 | 0.150 |
Why?
| | Wnt-5a Protein | 1 | 2017 | 18 | 0.140 |
Why?
| | Molecular Targeted Therapy | 2 | 2020 | 347 | 0.140 |
Why?
| | Disease Progression | 2 | 2015 | 2392 | 0.140 |
Why?
| | Glucuronidase | 1 | 2017 | 42 | 0.140 |
Why?
| | Gene Knockdown Techniques | 2 | 2019 | 299 | 0.140 |
Why?
| | Cell Line | 4 | 2023 | 2640 | 0.140 |
Why?
| | Cell Survival | 4 | 2015 | 1022 | 0.140 |
Why?
| | Adenosine Triphosphate | 1 | 2019 | 431 | 0.140 |
Why?
| | Endopeptidase Clp | 1 | 2016 | 4 | 0.140 |
Why?
| | Microtubules | 1 | 2019 | 237 | 0.140 |
Why?
| | Mice, SCID | 2 | 2016 | 320 | 0.130 |
Why?
| | Lactams, Macrocyclic | 2 | 2013 | 46 | 0.130 |
Why?
| | Thiazolidinediones | 1 | 2017 | 142 | 0.130 |
Why?
| | Isoenzymes | 3 | 2013 | 285 | 0.130 |
Why?
| | Metabolic Networks and Pathways | 1 | 2016 | 168 | 0.130 |
Why?
| | Fibroblasts | 1 | 2020 | 839 | 0.130 |
Why?
| | Adaptation, Biological | 1 | 2015 | 54 | 0.130 |
Why?
| | Elafin | 1 | 2015 | 1 | 0.120 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2017 | 193 | 0.120 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 1361 | 0.120 |
Why?
| | Protein Kinase Inhibitors | 3 | 2020 | 796 | 0.120 |
Why?
| | Down-Regulation | 1 | 2016 | 596 | 0.120 |
Why?
| | Phorbol Esters | 2 | 2011 | 15 | 0.120 |
Why?
| | Biological Transport | 1 | 2015 | 372 | 0.120 |
Why?
| | Tetradecanoylphorbol Acetate | 3 | 2010 | 153 | 0.120 |
Why?
| | Cell Adhesion | 1 | 2015 | 430 | 0.110 |
Why?
| | Proto-Oncogene Proteins c-rel | 1 | 2013 | 8 | 0.110 |
Why?
| | Autophagy-Related Protein-1 Homolog | 1 | 2013 | 6 | 0.110 |
Why?
| | Hexokinase | 1 | 2013 | 11 | 0.110 |
Why?
| | Regulatory Elements, Transcriptional | 1 | 2013 | 16 | 0.110 |
Why?
| | Adenylate Kinase | 1 | 2013 | 27 | 0.110 |
Why?
| | Mitochondrial Membranes | 1 | 2013 | 33 | 0.110 |
Why?
| | Carcinogens | 2 | 2011 | 105 | 0.110 |
Why?
| | Skin Neoplasms | 1 | 2020 | 762 | 0.110 |
Why?
| | Oxygen Consumption | 1 | 2015 | 588 | 0.100 |
Why?
| | Unfolded Protein Response | 1 | 2012 | 43 | 0.100 |
Why?
| | Glioblastoma | 1 | 2015 | 253 | 0.100 |
Why?
| | Guanosine Triphosphate | 1 | 2012 | 85 | 0.100 |
Why?
| | Genes, bcl-2 | 1 | 2011 | 20 | 0.100 |
Why?
| | Gene Regulatory Networks | 1 | 2013 | 228 | 0.100 |
Why?
| | Clinical Trials as Topic | 1 | 2015 | 934 | 0.090 |
Why?
| | Up-Regulation | 3 | 2023 | 812 | 0.090 |
Why?
| | Male | 10 | 2022 | 55663 | 0.090 |
Why?
| | Rift Valley fever virus | 1 | 2010 | 2 | 0.090 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2011 | 139 | 0.090 |
Why?
| | Protein Kinase C-alpha | 2 | 2008 | 41 | 0.090 |
Why?
| | Kaplan-Meier Estimate | 1 | 2013 | 817 | 0.090 |
Why?
| | Protein Processing, Post-Translational | 1 | 2013 | 399 | 0.090 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2013 | 386 | 0.090 |
Why?
| | Etoposide | 1 | 2011 | 148 | 0.090 |
Why?
| | Insecta | 1 | 2010 | 65 | 0.090 |
Why?
| | Diglycerides | 1 | 2010 | 55 | 0.090 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2010 | 144 | 0.090 |
Why?
| | GTPase-Activating Proteins | 1 | 2010 | 71 | 0.090 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2011 | 181 | 0.080 |
Why?
| | Promoter Regions, Genetic | 1 | 2013 | 1133 | 0.080 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2011 | 744 | 0.080 |
Why?
| | Extracellular Matrix | 1 | 2012 | 436 | 0.080 |
Why?
| | S Phase | 1 | 2007 | 70 | 0.070 |
Why?
| | Peptide Fragments | 1 | 2011 | 668 | 0.070 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2007 | 107 | 0.070 |
Why?
| | Brain Neoplasms | 1 | 2015 | 987 | 0.070 |
Why?
| | Checkpoint Kinase 1 | 1 | 2006 | 28 | 0.070 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2006 | 108 | 0.070 |
Why?
| | Tumor Microenvironment | 2 | 2020 | 434 | 0.060 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2010 | 1134 | 0.060 |
Why?
| | Mice, Inbred NOD | 2 | 2016 | 561 | 0.060 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1523 | 0.060 |
Why?
| | DNA Damage | 1 | 2006 | 357 | 0.060 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2017 | 706 | 0.060 |
Why?
| | Pentose Phosphate Pathway | 1 | 2023 | 48 | 0.050 |
Why?
| | Glutamine | 1 | 2023 | 91 | 0.050 |
Why?
| | Nucleotides | 1 | 2023 | 112 | 0.050 |
Why?
| | Neoplastic Processes | 1 | 2022 | 4 | 0.050 |
Why?
| | Protein Folding | 2 | 2015 | 239 | 0.050 |
Why?
| | Glycolysis | 1 | 2023 | 227 | 0.050 |
Why?
| | Models, Biological | 1 | 2009 | 1630 | 0.050 |
Why?
| | Autophagy-Related Protein 7 | 1 | 2021 | 5 | 0.050 |
Why?
| | Autophagy-Related Proteins | 1 | 2021 | 39 | 0.050 |
Why?
| | Cytosol | 2 | 2012 | 208 | 0.050 |
Why?
| | Lysosomes | 1 | 2021 | 123 | 0.050 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2022 | 168 | 0.040 |
Why?
| | Cell Death | 1 | 2022 | 325 | 0.040 |
Why?
| | Dermis | 1 | 2020 | 30 | 0.040 |
Why?
| | Endosomes | 1 | 2021 | 124 | 0.040 |
Why?
| | Muscle Proteins | 1 | 2022 | 210 | 0.040 |
Why?
| | Voltage-Dependent Anion Channels | 1 | 2019 | 2 | 0.040 |
Why?
| | Pyruvates | 1 | 2019 | 20 | 0.040 |
Why?
| | Mitochondrial Membrane Transport Proteins | 1 | 2019 | 30 | 0.040 |
Why?
| | Citric Acid Cycle | 1 | 2019 | 43 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2020 | 201 | 0.040 |
Why?
| | Dihydrotestosterone | 1 | 2019 | 39 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2022 | 536 | 0.040 |
Why?
| | Keratinocytes | 1 | 2020 | 216 | 0.040 |
Why?
| | Receptors, Androgen | 1 | 2019 | 131 | 0.040 |
Why?
| | Glucose | 1 | 2023 | 897 | 0.040 |
Why?
| | Lipid Metabolism | 1 | 2020 | 446 | 0.040 |
Why?
| | Female | 4 | 2016 | 59581 | 0.030 |
Why?
| | Succinate Dehydrogenase | 1 | 2016 | 42 | 0.030 |
Why?
| | Transplantation, Heterologous | 1 | 2016 | 183 | 0.030 |
Why?
| | PPAR gamma | 1 | 2017 | 183 | 0.030 |
Why?
| | Cell Hypoxia | 1 | 2016 | 220 | 0.030 |
Why?
| | Protein Subunits | 1 | 2016 | 201 | 0.030 |
Why?
| | Rats | 1 | 2023 | 4963 | 0.030 |
Why?
| | Cell Cycle | 2 | 2008 | 544 | 0.030 |
Why?
| | Cyclophilins | 1 | 2015 | 29 | 0.030 |
Why?
| | Indoles | 1 | 2017 | 306 | 0.030 |
Why?
| | Drug Synergism | 1 | 2015 | 316 | 0.030 |
Why?
| | Sulfonamides | 1 | 2017 | 445 | 0.030 |
Why?
| | Mutation | 2 | 2017 | 3354 | 0.030 |
Why?
| | Immunocompromised Host | 1 | 2015 | 196 | 0.030 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2012 | 96 | 0.020 |
Why?
| | Heat-Shock Proteins | 1 | 2012 | 113 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2013 | 855 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2013 | 337 | 0.020 |
Why?
| | Multiprotein Complexes | 1 | 2012 | 140 | 0.020 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2012 | 175 | 0.020 |
Why?
| | Benzophenanthridines | 1 | 2010 | 10 | 0.020 |
Why?
| | Acetophenones | 1 | 2010 | 14 | 0.020 |
Why?
| | Benzopyrans | 1 | 2010 | 25 | 0.020 |
Why?
| | Vero Cells | 1 | 2010 | 63 | 0.020 |
Why?
| | bcl-Associated Death Protein | 1 | 2010 | 5 | 0.020 |
Why?
| | Diptera | 1 | 2010 | 27 | 0.020 |
Why?
| | Proteomics | 1 | 2016 | 844 | 0.020 |
Why?
| | Endoplasmic Reticulum | 1 | 2012 | 234 | 0.020 |
Why?
| | Immunoblotting | 1 | 2010 | 283 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2016 | 2587 | 0.020 |
Why?
| | Age Factors | 1 | 2017 | 2891 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2010 | 396 | 0.020 |
Why?
| | COS Cells | 1 | 2010 | 175 | 0.020 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2012 | 359 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2018 | 4719 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2010 | 593 | 0.020 |
Why?
| | HeLa Cells | 1 | 2010 | 562 | 0.020 |
Why?
| | beta-Galactosidase | 1 | 2007 | 62 | 0.020 |
Why?
| | Adenoviridae | 1 | 2008 | 185 | 0.020 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2010 | 399 | 0.020 |
Why?
| | Middle Aged | 2 | 2017 | 26806 | 0.020 |
Why?
| | Proteins | 1 | 2012 | 912 | 0.020 |
Why?
| | Telomerase | 1 | 2007 | 206 | 0.020 |
Why?
| | Adult | 2 | 2017 | 30608 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2016 | 6364 | 0.020 |
Why?
| | Neurons | 1 | 2010 | 1282 | 0.010 |
Why?
| | Aged | 1 | 2016 | 19122 | 0.010 |
Why?
|
|
Caino's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|